Neoadjuvant immunotherapy with relatlimab and nivolumab is safe and effective in stage III melanoma
MedicalXpress Breaking News-and-Events | Oct 28, 2022
New computer platform helps match patients with cancer to trials of targeted therapy
MedicalXpress Breaking News-and-Events | Oct 15, 2022
Technological advances in cancer therapy
MedicalXpress Breaking News-and-Events | Sep 03, 2022
Ceritinib offers a promising target for cancer immunotherapy
MedicalXpress Breaking News-and-Events | Aug 26, 2022
Cells are able to 'talk to themselves' for better immune response
MedicalXpress Breaking News-and-Events | Aug 10, 2022
Carbon oxide gas boosts photothermal therapy under mild temperature
MedicalXpress Breaking News-and-Events | Aug 02, 2022
Hearing loss and tinnitus are common in cancer survivors
MedicalXpress Breaking News-and-Events | Jul 29, 2022
Whole exome sequencing predicts whether patients respond to cancer immunotherapy
MedicalXpress Breaking News-and-Events | Jul 12, 2022